122 related articles for article (PubMed ID: 14574270)
41. Fluorescein angiography in the follow-up study of choroidal melanoma after 106Ru/106Rh plaque therapy.
Lommatzsch PK; Ballin RE; Helm W
Retina; 1987; 7(3):148-55. PubMed ID: 3423430
[TBL] [Abstract][Full Text] [Related]
42. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
[TBL] [Abstract][Full Text] [Related]
43. Plaque radiotherapy for juxtapapillary choroidal melanoma. Visual acuity and survival outcome.
De Potter P; Shields CL; Shields JA; Cater JR; Brady LW
Arch Ophthalmol; 1996 Nov; 114(11):1357-65. PubMed ID: 8906026
[TBL] [Abstract][Full Text] [Related]
44. Management of exudative retinal detachment in choroidal melanoma.
Gibran SK; Kapoor KG
Clin Exp Ophthalmol; 2009 Sep; 37(7):654-9. PubMed ID: 19788660
[TBL] [Abstract][Full Text] [Related]
45. [Tyndallometry for follow-up of iodine-125 brachytherapy of uveal malignant melanomas. Report of 2 patients].
Nguyen NX; Küchle M; Strunk W
Klin Monbl Augenheilkd; 1996 Jul; 209(1):25-30. PubMed ID: 8965473
[TBL] [Abstract][Full Text] [Related]
46. Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal Melanoma.
AlMahmoud T; Quinlan-Davidson S; Pond GR; Deschênes J
Middle East Afr J Ophthalmol; 2018; 25(2):103-107. PubMed ID: 30122856
[TBL] [Abstract][Full Text] [Related]
47. Patterns of indocyanine green videoangiography of choroidal tumours.
Shields CL; Shields JA; De Potter P
Br J Ophthalmol; 1995 Mar; 79(3):237-45. PubMed ID: 7703202
[TBL] [Abstract][Full Text] [Related]
48. Long-term results of iodine 125 irradiation of uveal melanoma.
Packer S; Stoller S; Lesser ML; Mandel FS; Finger PT
Ophthalmology; 1992 May; 99(5):767-73; discussion 774. PubMed ID: 1594224
[TBL] [Abstract][Full Text] [Related]
49. Intraoperative sonographically assisted radioactive iodine 125 plaque brachytherapy for choroidal melanoma: visual acuity outcome.
Quinlan-Davidson S; AlMahmoud T; Shenouda G; Evans M; Mansour M; Edelstein C; Pond G; Deschênes J
J Ultrasound Med; 2013 Jun; 32(6):995-1001. PubMed ID: 23716521
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and Safety of Low-Dose Iodine Plaque Brachytherapy for Juxtapapillary Choroidal Melanoma.
Oellers P; Mowery YM; Perez BA; Stinnett S; Mettu P; Vajzovic L; Light K; Steffey BA; Cai J; Dutton JJ; Buckley EG; Halperin EC; Marks LB; Kirsch DG; Mruthyunjaya P
Am J Ophthalmol; 2018 Feb; 186():32-40. PubMed ID: 29199010
[TBL] [Abstract][Full Text] [Related]
51. Necrotic choroidal melanoma with scleritis and choroidal effusion.
Palamar M; Thangappan A; Shields CL; Ehya H; Shields JA
Cornea; 2009 Apr; 28(3):354-6. PubMed ID: 19387243
[TBL] [Abstract][Full Text] [Related]
52. Choroidal melanoma in children: be aware of risks.
Sivalingam MD; Hasanreisoglu M; Shields CL
J Pediatr Ophthalmol Strabismus; 2014 Dec; 51 Online():e85-8. PubMed ID: 25490240
[TBL] [Abstract][Full Text] [Related]
53. Iodine-125 irradiation of choroidal melanoma: clinical experience from the Prince of Wales and Sydney Eye Hospitals.
Mameghan H; Karolis C; Fisher R; Mameghan J; Billson FA; Donaldson EJ; Giblin ME; Hunyor AB
Australas Radiol; 1992 Aug; 36(3):249-52. PubMed ID: 1445109
[TBL] [Abstract][Full Text] [Related]
54. Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy.
Nishijima K; Takahashi M; Akita J; Katsuta H; Tanemura M; Aikawa H; Mandai M; Takagi H; Kiryu J; Honda Y
Am J Ophthalmol; 2004 Apr; 137(4):770-3. PubMed ID: 15059729
[TBL] [Abstract][Full Text] [Related]
55. Planned combined I-125 plaque irradiation and indirect ophthalmoscope laser therapy for choroidal malignant melanoma.
Augsburger JJ; Mullen D; Kleineidam M
Ophthalmic Surg; 1993 Feb; 24(2):76-81. PubMed ID: 8446358
[TBL] [Abstract][Full Text] [Related]
56. Laser photocoagulation of indocyanine green aniographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy.
Lai TY; Chan WM; Lam DS
Am J Ophthalmol; 2004 Oct; 138(4):693-4; author reply 694. PubMed ID: 15488830
[No Abstract] [Full Text] [Related]
57. Regression patterns of choroidal melanoma: After palladium-103 (
Maheshwari A; Finger PT
Eur J Ophthalmol; 2018 Nov; 28(6):722-730. PubMed ID: 29788760
[TBL] [Abstract][Full Text] [Related]
58. Iodine-125 irradiation of choroidal melanoma. Clinical experience.
Packer S; Rotman M; Salanitro P
Ophthalmology; 1984 Dec; 91(12):1700-8. PubMed ID: 6521999
[TBL] [Abstract][Full Text] [Related]
59. Management of radiation maculopathy.
Singh AD; Pabon S; Aronow ME
Ophthalmic Res; 2012; 48 Suppl 1():26-31. PubMed ID: 22907147
[TBL] [Abstract][Full Text] [Related]
60. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
